Seven Grand Managers’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-50,000
Closed -$1.23M – 203
2026
Q2
$1.23M Hold
50,000
– – 0.05% 154
2026
Q1
$874K Buy
+50,000
New +$963K 0.06% 152

Other funds holding BIOA

Seven Grand Managers's BIOA Position: Q3 2026 in Review

Seven Grand Managers sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 50,000 shares — an estimated $1.23M sold.

Seven Grand Managers first reported a position in BIOA in Q1 2026 and held it in 2 quarters. The position peaked at $1.23M in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Seven Grand Managers reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
  • Seven Grand Managers sold 50,000 BioAge Labs shares in Q3 2026, an estimated $1.23M.
  • Seven Grand Managers first reported a position in BioAge Labs in Q1 2026 and held it in 2 quarters.
  • Seven Grand Managers's BioAge Labs position peaked at $1.23M in Q2 2026.
  • 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.